Skip to main content
. 2020 Sep 17;20:100921. doi: 10.1016/j.ajoc.2020.100921

Fig. 1.

Fig. 1

Case 6 presenting with a relapse of disease activity Indocyanine green (ICG) pictures at 30 minutes and fundus pictures taken A + B. before the start of adalimumab whilst treated with ciclosporin A 200mg, mycophenolate mofetil 2000mg and prednisolone 10mg daily and C. during treatment with adalimumab 40mg/2 weeks, mycophenolate mofetil 2000mg and prednisolone 7.5mg daily A. 4 months before the start of adalimumab with almost complete quiescent disease except for one spot of choroiditis (black arrow). B. One month before the start of adalimumab, ICG angiography shows a relapse of disease activity with multiple spots of choroiditis (black arrows) and the fundus image shows one white-yellowish lesion (black arrow). C. Eight months after the start of adalimumab, imaging shows complete remission of disease activity. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)